These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 7722124
41. Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial). Bovill EG, Tracy RP, Knatterud GL, Stone PH, Nasmith J, Gore JM, Thompson BW, Tofler GH, Kleiman NS, Cannon C, Braunwald E. Am J Cardiol; 1997 Feb 15; 79(4):391-6. PubMed ID: 9052337 [Abstract] [Full Text] [Related]
42. Comparison of clinical outcome of fixed-dose subcutaneous low molecular weight heparin (tinzaparin) with conventional heparin in unstable angina: a pilot study. Suvarna TT, Parikh JA, Keshav R, Pillai MG, Pahlajani DB, Gandhi MJ. Indian Heart J; 1997 Feb 15; 49(2):159-62. PubMed ID: 9231547 [Abstract] [Full Text] [Related]
43. Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty. Doucet S, Malekianpour M, Théroux P, Bilodeau L, Côté G, de Guise P, Dupuis J, Joyal M, Gosselin G, Tanguay JF, Juneau M, Harel F, Nattel S, Tardif JC, Lespérance J. Circulation; 2000 Mar 07; 101(9):955-61. PubMed ID: 10704160 [Abstract] [Full Text] [Related]
44. Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. J Am Coll Cardiol; 2001 Feb 07; 37(2):475-84. PubMed ID: 11216966 [Abstract] [Full Text] [Related]
45. Thrombolysis in unstable angina: results of clinical studies. Scrutinio D, Biasco MG, Rizzon P. Am J Cardiol; 1991 Sep 03; 68(7):99B-104B. PubMed ID: 1892074 [Abstract] [Full Text] [Related]
46. Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group. Neri Serneri GG, Modesti PA, Gensini GF, Branzi A, Melandri G, Poggesi L, Rostagno C, Tamburini C, Carnovali M, Magnani B. Lancet; 1995 May 13; 345(8959):1201-4. PubMed ID: 7739307 [Abstract] [Full Text] [Related]
47. Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina. Wieczorek I, Ludlam CA, Fox KA. Am J Cardiol; 1994 Sep 01; 74(5):424-9. PubMed ID: 8059719 [Abstract] [Full Text] [Related]
48. Randomized clinical trial of urokinase versus heparin in unstable angina. Chen JL. J Thromb Thrombolysis; 1999 Oct 01; 8(3):223-6. PubMed ID: 10500312 [Abstract] [Full Text] [Related]
53. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Lancet; 1988 Sep 03; 2(8610):525-30. PubMed ID: 2900919 [Abstract] [Full Text] [Related]
55. Thrombosis in unstable angina. Chesebro JH, Fuster V. N Engl J Med; 1992 Jul 16; 327(3):192-4. PubMed ID: 1608410 [No Abstract] [Full Text] [Related]
56. Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris. Olausson K, Magnusdottir H, Lurje L, Wennerblom B, Emanuelsson H, Ricksten SE. Circulation; 1997 Oct 07; 96(7):2178-82. PubMed ID: 9337187 [Abstract] [Full Text] [Related]
58. Management of thrombosis in coronary heart disease. de Bono D. Br Med Bull; 1994 Oct 07; 50(4):904-10. PubMed ID: 7804737 [Abstract] [Full Text] [Related]